BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6992235)

  • 1. Comparison in anesthetized dogs of the anti-aggregatory and hemodynamic effects of prostacyclin and a chemically stable prostacyclin analog, 6a-carba-PGI2 (carbacyclin).
    Aiken JW; Shebuski RJ
    Prostaglandins; 1980 Apr; 19(4):629-43. PubMed ID: 6992235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbacyclin--a potent stable prostacyclin analogue for the inhibition of platelet aggregation.
    Whittle BJ; Moncada S; Whiting F; Vane JR
    Prostaglandins; 1980 Apr; 19(4):605-27. PubMed ID: 6992234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A chemically stable analogue, 9 beta-methyl carbacyclin, with similar effects to epoprostenol (prostacyclin, PGI2) in man.
    O'Grady J; Hedges A; Whittle BJ; Al-Sinawi LA; Mekki QA; Burke C; Moody SG; Moti MJ; Hassan S
    Br J Clin Pharmacol; 1984 Dec; 18(6):921-33. PubMed ID: 6085004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cardiovascular and platelet actions of 9 beta-methyl carbacyclin (ciprostene), a chemically stable analogue of prostacyclin, in the dog and monkey.
    Allan G; Follenfant MJ; Lidbury P; Oliver PL; Whittle BJ
    Br J Pharmacol; 1985 Jun; 85(2):547-55. PubMed ID: 3896365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the inhibitory effects of prostacyclin and carbacyclin on platelet adhesion to collagen.
    Karniguian A; Simmons P; Legrand YJ; Moncada S; Caen JP
    Prostaglandins; 1982 Dec; 24(6):827-36. PubMed ID: 6300971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration of prostacyclin prevents ventricular fibrillation following coronary occlusion in conscious dogs.
    Starnes VA; Primm RK; Woosley RL; Oates JA; Hammon JW
    J Cardiovasc Pharmacol; 1982; 4(5):765-9. PubMed ID: 6182407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of prostacyclin on hemodynamic and coronary blood flow in dogs.
    Teesalu R; Kòrgevee A
    Biomed Biochim Acta; 1988; 47(10-11):S56-9. PubMed ID: 3073770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of platelet aggregation and reversal of vasopressin-induced ECG changes by a carboprostacyclin analogue, ONO 41483, in primates.
    Adaikan PG; Kottegoda SR; Lau LC; Tai MY; Karim SM
    Prostaglandins Leukot Med; 1982 Sep; 9(3):307-20. PubMed ID: 6752959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary vasodilator activity of 13,14-dehydroprostacyclin methyl ester: comparison with prostacyclin and other prostanoids.
    Hyman AL; Kadowitz PJ; Lands WE; Crawford CG; Fried J; Barton J
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3522-6. PubMed ID: 356056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociation between hemodynamic and platelet antiaggregant effects of prostacyclin in dogs determined with a rapid platelet isolation technique.
    Czer GT; Moser KM
    J Lab Clin Med; 1983 Jul; 102(1):133-9. PubMed ID: 6343535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular actions of prostacyclin (PGI2) in the cat.
    Lippton HL; Paustian PW; Mellion BT; Nelson PK; Feigen LP; Chapnick BM; Hyman AL; Kadowitz PJ
    Arch Int Pharmacodyn Ther; 1979 Sep; 241(1):121-30. PubMed ID: 393193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (5Z)-carbacyclin displays agonist-antagonist properties on prostacyclin-receptors in platelets and vascular myocytes.
    Corsini A; Oliva D; Folco GC; Giovanazzi S; Noe' MA; Fumagalli R; Nicosia S
    Biomed Biochim Acta; 1988; 47(10-11):S104-7. PubMed ID: 3073757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of prostacyclin on some hemodynamic parameters in dogs.
    Filczewski M; Oledzka K
    Pol J Pharmacol Pharm; 1981; 33(5):491-8. PubMed ID: 7038645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostacyclin (PGI2) induces coronary vasodilatation in anaesthetised dogs.
    Dusting GJ; Chapple DJ; Hughes R; Moncada S; Vane JR
    Cardiovasc Res; 1978 Dec; 12(12):720-30. PubMed ID: 376143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The orally active thia-imino-prostacyclin Hoe 892: antiaggregatory and cardiovascular activities.
    Schölkens BA; Gehring D; Jung W
    Prostaglandins Leukot Med; 1983 Mar; 10(3):231-56. PubMed ID: 6405394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic responses to prostacyclin (PGI2) in the conscious sheep.
    Kubo K; Kobayashi T; Yoshimura K; Fukushima M; Handa K; Kusama S; Sakai A; Ueda G
    Jpn Circ J; 1982 Dec; 46(12):1292-304. PubMed ID: 6754986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraarterial 9-beta-methyl carbacyclin improves canine polytetrafluoroethylene graft patency.
    Dacey LJ; Hees PS; Cronenwett JL
    J Vasc Surg; 1988 Jul; 8(1):21-7. PubMed ID: 3133494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of prostacyclin on systemic and coronary hemodynamics in the dog.
    Mehta J; Nichols WW; Mehta P; Pepine C; Conti CR
    Am Heart J; 1981 Nov; 102(5):835-40. PubMed ID: 7030040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric antisecretory and cardiovascular actions of a stable 16-phenoxy prostacyclin analog in the dog.
    Kauffman GL; Whittle BJ; Aures D; Grossman MI
    Adv Prostaglandin Thromboxane Res; 1980; 8():1521-4. PubMed ID: 6990722
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological profile of a novel carbacyclin derivative with high metabolic stability and oral activity in the rat.
    Stürzebecher S; Haberey M; Müller B; Schillinger E; Schröder G; Skuballa W; Stock G; Vorbrüggen H; Witt W
    Prostaglandins; 1986 Jan; 31(1):95-109. PubMed ID: 3513260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.